Received tentative approval from the FDA for YUTREPIATM (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) ...

A cross-sectional study found the prevalence of idiopathic intracranial hypertension among women in the United States varied ...

U.S. stock index futures turned positive on Wednesday after an in-line reading of the consumer price index did little to ...

High inflation in Britain has not been vanquished and there is a risk that some drivers of price growth could be heading ...

In the realm of cardiovascular health, hypertension stands out as the most prevalent, yet preventable, risk factor, impacting millions globally. Despite the availability of numerous treatments, ...

Water-resource managers and urban planners could be more confident that they were using the most current scenarios and ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...

Intracranial hypertension—elevated pressure within the skull—poses life-threatening risks, including strokes, hemorrhages, ...

Except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in ...

The company has made upfront payments and has future obligations, including milestone payments ... and safety of lorundrostat ...

New research suggests early sugar habits can shape our health and maybe our taste for food. Can we can change our preferences ...